Outcomes of patients with AML according to the number of CRs/CRis (first vs second) and the MRD status at allogeneic HSCT (positive vs negative; n = 300). (A) CIR. MRD⁺ vs MRD⁻: first CR/CRi (P < .001) and second CR/CRi (P < .001). (B) RFS. MRD⁺ vs MRD⁻ first CR/CRi (P = .002) and second CR/CRi (P = .04). (C) OS. MRD⁺ vs MRD⁻: first CR/Cri (P = .07) and second CR/Cri (P > .99).